These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The relationship between tumour proliferative activity, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Canna K; Hilmy M; McMillan DC; Smith GW; McKee RF; McArdle CS; McNicol AM Colorectal Dis; 2008 Sep; 10(7):663-7. PubMed ID: 18005189 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer. Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324 [TBL] [Abstract][Full Text] [Related]
5. Relationship between emergency presentation, systemic inflammatory response, and cancer-specific survival in patients undergoing potentially curative surgery for colon cancer. Crozier JE; Leitch EF; McKee RF; Anderson JH; Horgan PG; McMillan DC Am J Surg; 2009 Apr; 197(4):544-9. PubMed ID: 18614139 [TBL] [Abstract][Full Text] [Related]
6. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate. Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761 [TBL] [Abstract][Full Text] [Related]
7. Predictive role of thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer patients receiving adjuvant 5-fluorouracil. Ciaparrone M; Quirino M; Schinzari G; Zannoni G; Corsi DC; Vecchio FM; Cassano A; La Torre G; Barone C Oncology; 2006; 70(5):366-77. PubMed ID: 17179731 [TBL] [Abstract][Full Text] [Related]
8. Recurrence and survival after potentially curative surgery for colorectal cancer. Jadallah F; McCall JL; van Rij AM N Z Med J; 1999 Jul; 112(1091):248-50. PubMed ID: 10448981 [TBL] [Abstract][Full Text] [Related]
9. Prognosis in Duke's B colorectal carcinoma: the Jass classification revisited. De Quay N; Cerottini JP; Albe X; Saraga E; Givel JC; Caplin S Eur J Surg; 1999 Jun; 165(6):588-92. PubMed ID: 10433145 [TBL] [Abstract][Full Text] [Related]
10. Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC Br J Surg; 2007 Aug; 94(8):1028-32. PubMed ID: 17437250 [TBL] [Abstract][Full Text] [Related]
11. Glasgow prognostic score as a prognostic factor in patients undergoing curative surgery for colorectal cancer. Sugimoto K; Komiyama H; Kojima Y; Goto M; Tomiki Y; Sakamoto K Dig Surg; 2012; 29(6):503-9. PubMed ID: 23392422 [TBL] [Abstract][Full Text] [Related]
12. The presence of a systemic inflammatory response predicts poorer survival in patients receiving adjuvant 5-FU chemotherapy following potentially curative resection for colorectal cancer. Crozier JE; McKee RF; McArdle CS; Angerson WJ; Anderson JH; Horgan PG; McMillan DC Br J Cancer; 2006 Jun; 94(12):1833-6. PubMed ID: 16721360 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection. Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108 [TBL] [Abstract][Full Text] [Related]
14. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patients undergoing potentially curative resection for renal cancer. Ramsey S; Lamb GW; Aitchison M; McMillan DC BJU Int; 2008 Apr; 101(8):959-63. PubMed ID: 18190639 [TBL] [Abstract][Full Text] [Related]
15. A critical review of the Glasgow Prognostic Score for colorectal cancer. Shedda S; Kosmider S; Faragher I; Jones I; Gibbs P Ann Surg; 2008 Jun; 247(6):1087-8; author reply 1088. PubMed ID: 18520255 [No Abstract] [Full Text] [Related]
16. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
17. Is C-reactive protein a prognostic factor of colorectal cancer? Shiu YC; Lin JK; Huang CJ; Jiang JK; Wang LW; Huang HC; Yang SH Dis Colon Rectum; 2008 Apr; 51(4):443-9. PubMed ID: 18172726 [TBL] [Abstract][Full Text] [Related]
18. Serum albumin: a prognostic indicator in patients with colorectal cancer. Heys SD; Walker LG; Deehan DJ; Eremin OE J R Coll Surg Edinb; 1998 Jun; 43(3):163-8. PubMed ID: 9654876 [TBL] [Abstract][Full Text] [Related]
19. Inflammation-based prognostic score is a novel predictor of postoperative outcome in patients with colorectal cancer. Ishizuka M; Nagata H; Takagi K; Horie T; Kubota K Ann Surg; 2007 Dec; 246(6):1047-51. PubMed ID: 18043109 [TBL] [Abstract][Full Text] [Related]